(Press-News.org) A number of important questions and issues should be addressed before changes are made to the guidelines for the diagnosis of gestational diabetes, according to a new article by University of Maryland School of Medicine Dean E. Albert Reece, M.D., Ph.D., M.B.A., published online in the American Journal of Obstetrics and Gynecology on Oct. 31. The article publishes in advance of a new National Institutes of Health (NIH) initiative to reconsider diagnostic guidelines for the condition.
The NIH Office of Disease Prevention has called a Consensus Development Conference in early 2013 to assess available scientific evidence. At the end of the conference, an independent panel will publicly disclose its findings, assessing and analyzing evidence including a literature review and expert presentations. In advance of the event and possible recommendations for changing diagnostic criteria, Dean Reece and co-author Thomas Moore, M.D., professor and chairman of the Department of Reproductive Medicine at the University of California, San Diego, urge caution in their article.
"Some in obstetrics and gynecology and maternal-fetal medicine have advocated for change to the diagnostic criteria for gestational diabetes for some time now," says Dean Reece, who is also vice president for medical affairs at the University of Maryland and John Z. and Akiko K. Bowers Distinguished Professor at the University of Maryland School of Medicine. "Others, including the American College of Obstetricians and Gynecologists, say it is not clear that change is needed. Dr. Moore and I have considered the arguments and evidence on both sides. We have concluded that before change is made, there needs to be careful analysis of the possible risk, cost and benefit involved in any revisions. If the data aren't available to answer these questions, it would seem prudent and advisable to delay change at this time."
Two additional articles, both asserting concerns about revisions to the diagnostic criteria, have been published electronically in other journals in advance of the conference. Both articles were co-authored by Oded Langer, M.D., Ph.D., maternal-fetal medicine expert at Cookeville Medical Regional Center in Tennessee; Jason G. Umans, M.D., Ph.D., F.A.C.P., scientific director of the MedStar Health Research Institute in Maryland and associate professor of medicine at Georgetown University; and Menachem Miodovnik, M.D., chairman of women's services at MedStar Washington Hospital Center. "Perspectives on the Proposed Gestational Diabetes Mellitus Diagnostic Criteria" appeared in the journal, Obstetrics & Gynecology, and "The proposed GDM diagnostic criteria: A difference, to be a difference, must make a difference" appeared in the Journal of Maternal-Fetal Neonatal Medicine.
The authors advised that "such a change would dramatically increase the number of women identified as having this disease and place a significantly greater burden on an already overburdened primary health care system."
Gestational diabetes is a condition that can be potentially devastating to pregnancies. Even mild forms of hyperglycemia could potentially pose significant adverse health consequences for pregnant women and their children. Advocates for changing diagnostic criteria — increasing the number of women diagnosed with and thus treated for the condition — could reduce morbidity and health care costs. Those cost reductions, however, could be offset by an increase in patients diagnosed and treated, according to Dean Reece.
Some studies have shown that such a change could potentially improve health outcomes for mothers and their babies, but at least one prominent study showed that the potential public health benefits will only occur if a higher level of care is given to newly diagnosed patients. Changing the criteria also could increase cesarean delivery rates, which could increase health care costs and offset any public health gains involved with diagnosing and treating more patients.
"The scientific dilemma to change or not to change, thus, requires a rigorous analysis of the scientific, economic, practice, and legal ramifications as well as the pros and cons to achieve a satisfactory answer," the article by Dean Reece and Dr. Moore concludes.
###
About the University of Maryland School of Medicine
Established in 1807, the University of Maryland School of Medicine is the first public medical school in the United States, and the first to institute a residency-training program. The School of Medicine was the founding school of the University of Maryland and today is an integral part of the 11-campus University System of Maryland. On the University of Maryland's Baltimore campus, the School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research and provide the best patient care and community service to Maryland and beyond. www.medschool.umaryland.edu.
END
LA JOLLA, CA – October 31, 2012 – Scientists at The Scripps Research Institute (TSRI) have discovered the first selective inhibitors of an important set of enzymes. The new inhibitors, and chemical probes based on them, now can be used to study the functions of enzymes known as diacylglycerol lipases (DAGL), their products, and the pathways they regulate. Early tests in mouse macrophages suggest that DAGL-inhibiting compounds might also have therapeutic uses, for they suppress the production of a pro-inflammatory molecule that has been implicated in rheumatoid arthritis ...
A new study from the Johns Hopkins Bloomberg School of Public Health and the Chronic Kidney Disease Prognosis Consortium found that chronic kidney disease and its complications were associated with a higher risk of death regardless of age. The findings were presented October 30 at the American Society of Nephrology conference in San Diego, Ca. and published in latest issue of JAMA.
Chronic kidney disease prevalence increases dramatically with age from 4 percent at age 20-39 to 54 percent of adults over age 75 in the populations studied. This led some groups to question ...
Eat a breakfast sandwich and your body will be feeling the ill effects well before lunch – now that's fast food!
High-fat diets are associated with developing atherosclerosis (narrowing of the arteries) over a lifetime. But how quickly can damage start?
Just one day of eating a fat-laden breakfast sandwich – processed cheese and meat on a bun – and "your blood vessels become unhappy," says Heart and Stroke Foundation researcher Dr. Todd Anderson, director of the Libin Cardiovascular Institute of Alberta and head of cardiac science at the University of Calgary.
Atherosclerosis ...
Researchers at the University of Minnesota's Center for Magnetic Resonance Research (CMRR) have found a small population of neurons that is involved in measuring time, which is a process that has traditionally been difficult to study in the lab.
In the study, which is published October 30 in the open access journal PLOS Biology, the researchers developed a task in which monkeys could only rely on their internal sense of the passage of time. Their task design eliminated all external cues which could have served as "clocks".
The monkeys were trained to move their eyes ...
New research has found that the transport of proteins into chloroplasts in plants is differentially regulated by the age of the chloroplast; upturning the previously accepted notion that this process is age-independent or only globally up- or down- regulated for all proteins. The research, led by Dr. Hsou-min Li, a Research Fellow from the Institute of Molecular Biology, Academia Sinica of Taiwan, is published October 30 in the open access journal PLOS Biology.
It's long been known that gene expression changes with age, for example, some genes are expressed in young ...
COPENHAGEN (31 October, 2012)—Feeding the world releases up to 17,000 megatonnes of carbon dioxide into the atmosphere annually, according to a new analysis released today by the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS). But while the emissions "footprint" of food production needs to be reduced, a companion policy brief by CCAFS lays out how climate change will require a complete recalibration of where specific crops are grown and livestock are raised.
Together, Climate Change and Food Systems (published in the 2012 Annual Review ...
Low calorie foods may help people lose weight but there is often a problem that people using them do not feel full. New research published in BioMed Central's open access journal Flavour shows that subtle manipulations of texture and creamy flavour can increase the expectation that a fruit yoghurt drink will be filling and suppress hunger regardless of actual calorific content.
There is a currently a debate about satiety, how full low calorie foods and drinks make people feel and for how long, and whether or not they actually make people eat or drink more because the ...
The biomass stored in forests is thought to play a critical role in mitigating the catastrophic effects of global climate change. New research published in BioMed Central's open access journal Carbon Balance and Management has used Lidar data collected by the Geoscience Laser Altimeter System (GLAS) aboard the Ice Cloud and Elevation Satellite (ICESat) to accurately measure the biomass of California. When the ICESat2 is launched in 2016 this method will be able to monitor biomass and other global data changes.
As part of the global carbon cycle it is thought that global ...
Eating at least two servings of oily fish a week is moderately but significantly associated with a reduced risk of stroke, finds a study published on bmj.com today.
But taking fish oil supplements doesn't seem to have the same effect, say the researchers.
Regular consumption of fish and long chain omega 3 fatty acids has been linked with a reduced risk of coronary heart disease and current guidelines recommend eating at least two portions of fish a week, preferably oily fish like mackerel and sardines. But evidence supporting a similar benefit for stroke remains unclear.
So ...
A study from the University of Calgary's Hotchkiss Brain Institute shows there is evidence to support a new drug therapy called nabilone to treat diabetic neuropathy, or nerve pain. Researchers enrolled 60 patients with diabetic neuropathy in a 12-week placebo controlled clinical study. At the end of the study, patients reported less pain and an improvement in sleep and anxiety when taking nabilone as compared to the placebo.
"This is a good option to help treat nerve pain due to diabetes, with very few side effects," says Dr. Cory Toth, a neurologist and the study's ...
